BioSpace News Archive

Bruker Corporation announced it will participate in the 2020 Wells Fargo Virtual Healthcare Conference.

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced that its Chairman and Chief Executive Officer Ming Hsieh, Chief Financial Officer Paul Kim, and Chief Commercial Officer Brandon Perthuis are scheduled to virtually participate in the H.C. Wainwright 22 nd Annual Global Investment Conference o

Global Blood Therapeutics, Inc. announced that on September 1, 2020, the compensation committee of GBT’s board of directors granted seven new employees options to purchase an aggregate of 11,678 shares of the company’s common stock with a per share exercise price of $60.45 and restricted stock units for an aggregate of 46,585 shares of the company’s common stock.

Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming Morgan Stanley 2020 Healthcare Conference. Silk Road Medical’s management is scheduled to present on Friday, September 18 at 11:45 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of t

Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that management will be participating in the following investor conferences in September 2020 :

UroGen Pharma Ltd. a biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases because patients deserve better options, announced the grants of inducement restricted stock units to nineteen new employees in connection with their employment with UroGen.

Brings over 20 years of commercial and medical expertise in the pharmaceutical industry and the cannabis space

Veracyte, Inc., a global genomic diagnostics company, announced that Bonnie H. Anderson, chairman and chief executive officer, is scheduled to participate in two upcoming virtual investor conferences

– Prescription Drug User Fee Act (PDUFA) target action date of June 25, 2021 – – FDA indicated that it is currently not planning to hold an Advisory Committee Meeting –

ViewRay, Inc. announced that the Company will participate in three upcoming virtual investor conferences